Scientific Committee

The role and procedure of ELA International Scientific Committee

A new scientific committee for ELA

The scientific committee of ELA International has 15 members, experts in leukodystrophies. It is chaired by Pr. Florian Eichler, Medical Neurologist Director of the Department of Leukodystrophies at Massachusetts General Hospital for Children – Boston, USA.
Nicole Wolf, nuropediatrician doctor at the VU University Medical Center of Amsterdam – Amsterdam, The Netherlands, has been appointed Vice President.

The scientific council is renewed. Today Magali Pettazzoni joins the committee, her expertise focuses on hereditary pathologies of metabolism and red blood cell, at CHU Lyon, France, Alessandra Biffi, Head of the Paediatric Haematology Department at the University Hospital of Padua, Italie and Annette Bley, Head of Leukodystrophies Pediatric Clinic at the Hamburg University Medical Center, Hamburg, Germany.

The scientific committee continues its mission to support ELA International in its research activities by providing its scientific expertise for the evaluation of projects related to the annual call for proposals.

Florian EICHLER
Nationality: American

President
MD

Pediatric and Adult Neurology
Director of the Leukodystrophy Service
Massachusetts General Hospital
Boston, MA, USA

Nicole WOLF
Nationality: Dutch

Vice-presidente

MD, PhD

Pediatric Neurology, Neurosciences
Neurology Center for Childhood White Matter Disorders
VUmc – VU University Medical Center Amsterdam
Amsterdam, The Netherlands

Elena AMBROSINI
Nationality: Italian

PhD

Neurobiology
Department of Cell Biology and Neuroscience
Instituto Superiore di Sanità
Rome, Italy

Enrico BERTINI
Nationality: Italian

MD

Professor of Pediatric Neurology
Head of the Neuromuscular and Neurodegenerative disease unit
Laboratory of Molecular Medicine
Ospedale Bambino Gesu Research Hospital
Rome, Italy

Annette BLEY
Nationality : German

MD

Head of Leukodystrophies Pediatric Clinic
Hamburg University Medical Center
Hamburg, Germany

Alessandra BIFFI
Nationality: Italian

MLD,

Gene Therapy

Professor of Pediatrics
Chief, Pediatric Hematology, Oncology and Stem Cell Transplant Division
Padua University Hospital, Italy

Raul ESTEVEZ
Nationality: Spanish

PhD

Professor of Physiology
University of Barcelona
Barcelona, Spain

Samuel GROESCHEL
Nationality: German

MD, PhD

Pediatric Neurology
University Children’s Hospital
Tuebingen, Germany

David HUNT
Nationality: English

MD, PhD

Molecular Biology and Inflammatory Diseases
University of Edinburgh
Edinburgh, UK

Stephan KEMP
Nationality: Dutch

PhD

Academic Medical Center Principal Investigator
Genetic Metabolic Diseases Department
University of Amsterdam
Amsterdam, The Netherlands

Wolfgang KOEHLER
Nationality: German

MD

Clinical neurology
MZEB
University Hospital Leipzig
Leipzig, Germany

Yann NADJAR
Nationality: French

MD, PhD Neurologist

Neuro-Genetics and Metabolism
Lysosomal Diseases Reference Center
La Pitié Salpêtrière Hospital
Paris, France

Magali PETTAZZONI
Nationality: French

PharmD

Department of Biochemistry and Molecular Biology
CHU de Lyon HCL - GH Est

Lyon, Paris

David ROWITCH
Nationality: American

MD, PhD, ScD

Pediatric Neurology
Professor and Head of Department University of Cambridge Adjunct Professor of Pediatrics and Neurosurgery, UCSF Cambridge, UK

Adeline VANDERVER
Nationality: American

MD

Neurology Program Director of the Leukodystrophy Center of Excellence
The Children’s Hospital of Philadelphia
Philadelphia, PA, USA


Ukraine – ELA Scientific committee statement

“The European Leukodystrophy Association international scientific advisory board wishes to express its concern and sympathy for people and families affected by leukodystrophy and the war in Ukraine. We understand the great difficulty of taking care of children with rare disease, especially without access to proper hospital care or medicines.

Our board members will endeavour to provide direct medical support to refugees as well as hospitals and healthcare providers in the region that can benefit from specialist medical advice on care of leukodystrophy patients.

This is a time of empathy and unity for all people and families affected by leukodystrophy”